inspra and Aminosyn ii 4 25 dextrose 25 electrolyte ca Interactions

Interactions between inspra(eplerenone) and Aminosyn ii 4 25 dextrose 25 electrolyte ca (parenteral nutrition solution w/electrolytes)

parenteral nutrition solution w/electrolytes and eplerenone (Major Drug-Drug)

CONTRAINDICATED: The principal risk of eplerenone is hyperkalemia. Coadministration with potassium salts or potassium-sparing diuretics may increase this risk due to additive pharmacodynamic effects.

MANAGEMENT: Given the potential for serious, sometimes fatal cardiac arrhythmias associated with hyperkalemia, the use of eplerenone with potassium salts or potassium-sparing diuretics is considered contraindicated.